Skip to main content

Table 2 Summary of Adverse Events

From: Safety and clinical activity of PD-L1 blockade in patients with aggressive recurrent respiratory papillomatosis

  Grade
No. of patients (%)
1 2 3 4
Fatigue 4 (33) 0 0 0
Malaise 1 (8) 0 0 0
Fever 2 (17) 0 0 0
Chills 1 (8) 0 0 0
Tachycardia 1 (8) 0 0 0
Headache 3 (25) 0 0 0
Anemia 2 (17) 0 0 0
Leukopenia 1 (8) 1 (8) 0 0
Neutropenia 0 1 (8) 0 0
Nausea 2 (17) 0 0 0
Constipation 1 (8) 0 0 0
Dysgeusia 1 (8) 0 0 0
Hyperthyroid 2 (17) 0 0 0
Hyperbilirubinemia 1 (8) 0 0 0
Increase in amlyase 1 (8) 0 0 0
Increase in lipase 2 (17) 0 0 0
Dry skin 0 1 (8) 0 0
Infusion reaction 0 1 (8) 0 0
Dry mouth 3 (25) 2 (17) 0 0
Maculopapular rash 1 (8) 0 0 0